Continental Advisors’s Gilead Sciences GILD Stock Holding History

Continental Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,000	Closed	-$2.1M	–	44
2024 Q3	$2.1M	Sell	25,000 -25,800	-51%	-$1.97M	1.01%	32
2024 Q2	$3.49M	Buy	50,800 +28,800	+131%	+$1.92M	1.53%	24
2024 Q1	$1.61M	Buy	+22,000	New	+$1.69M	0.65%	36
2023 Q1	–	Sell	-30,000	Closed	-$2.58M	–	54
2022 Q4	$2.58M	Sell	30,000 -15,000	-33%	-$1.19M	1.35%	28
2022 Q3	$2.78M	Sell	45,000 -10,000	-18%	-$631K	1.63%	25
2022 Q2	$3.4M	Sell	55,000 -25,000	-31%	-$1.55M	2.05%	17
2022 Q1	$4.76M	Buy	80,000 +30,000	+60%	+$1.92M	2.35%	14
2021 Q4	$3.63M	Hold	50,000	–	–	1.53%	22
2021 Q3	$3.49M	Buy	+50,000	New	+$3.51M	1.48%	29
2021 Q2	–	Sell	-10,000	Closed	-$646K	–	63
2021 Q1	$646K	Sell	10,000 -30,000	-75%	-$1.93M	0.3%	63
2020 Q4	$2.33M	Buy	40,000 +14,000	+54%	+$845K	1.06%	37
2020 Q3	$1.64M	Buy	26,000 +16,000	+160%	+$1.11M	0.87%	48
2020 Q2	$769K	Buy	+10,000	New	+$766K	0.41%	63
2018 Q4	–	Sell	-20,000	Closed	-$1.54M	–	105
2018 Q3	$1.54M	Sell	20,000 -13,000	-39%	-$982K	0.34%	75
2018 Q2	$2.34M	Buy	33,000 +20,000	+154%	+$1.41M	0.58%	59
2018 Q1	$980K	Sell	13,000 -17,000	-57%	-$1.35M	0.25%	80
2017 Q4	$2.15M	Sell	30,000 -19,600	-40%	-$1.49M	0.46%	68
2017 Q3	$4.02M	Sell	49,600 -65,400	-57%	-$5M	0.92%	43
2017 Q2	$8.14M	Sell	115,000 -55,000	-32%	-$3.66M	1.84%	11
2017 Q1	$11.5M	Buy	170,000 +80,000	+89%	+$5.63M	2.58%	4
2016 Q4	$6.45M	Buy	90,000 +85,000	+1,700%	+$6.32M	1.75%	12
2016 Q3	$396K	Buy	+5,000	New	+$406K	0.11%	129

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Continental Advisors's GILD Position: Q1 2026 in Review

Continental Advisors reduced its Gilead Sciences (GILD) stake by 14% in Q1 2026, selling an estimated $630K and leaving 28,367 shares worth $3.95M. The position accounts for 2.02% of the portfolio, ranked #18.

Continental Advisors first reported a position in GILD in Q3 2016 and has held it in 39 quarters since. The position peaked at $8.53M in Q2 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Continental Advisors held 28,367 shares of Gilead Sciences worth $3.95M as of Q1 2026.
Continental Advisors sold 4,500 Gilead Sciences shares in Q1 2026, an estimated $630K.
Gilead Sciences made up 2.02% of Continental Advisors's portfolio in Q1 2026, its #18 holding.
Continental Advisors first reported a position in Gilead Sciences in Q3 2016 and has held it in 39 quarters since.
Continental Advisors's Gilead Sciences position peaked at $8.53M in Q2 2021.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Continental Advisors's 13F filing for Q1 2026, filed 15 May 2026.